OECD Home › Health › Biotechnology policies › Latest Documents
English, , 1,579kb
In 2003 the OECD ran a large-scale survey on molecular genetic testing laboratory practices across 18 OECD countries. The survey was completed October 31, 2003. This report highlights short-term objectives of the survey.
Statistical work on biotechnology is carried out under the aegis of the OECD Working Party of National Experts on Science and Technology Indicators (NESTI). The above document gives the outcome of the 2004 experts' meeting.
Biological resources are the foundation of all biological sciences research. They provide the source material for scientific investigation, leading to many of the discoveries on which biotechnology is founded.
This document reflects recent efforts made by the OECD to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
English, , 327kb
The OECD should strengthen its contribution to work on biotechnology as a driver for sustainable growth, focusing on the issues identified and conclusions reached in this paper.
English, , 365kb
This guidance provides the basis for best practice in the management of biological resource centres and all laboratories maintaining replicable biological materials.
English, , 260kb
This document provides a framework for the national certification (independent review by third party) of biological resource centres as defined by the OECD. Compliance with this guidance is mandatory for those bodies that are part of a Global Biological Resource Centre Network.
As biotechnology becomes increasingly viewed as a strategic sector, the need for reliable statistics from which informed policy decisions can be made grows. This report provides an update on the biotechnology industry, based on primarily official statistical sources.
This paper provides input and a framework for a broader discussion of the identification of user needs that should inform the development of biotechnology statistics and indicators.
This booklet describes how biotechnology and genomics science can be used to fight neglected infectious diseases as well as reviewing the challenges facing Governments to overcome market failure in supply of products. It draws on discussions a...